Home › Funds › ACT Capital Partners, L.P. › NUVB
ACT Capital Partners, L.P. position in NUVB
NUVATION BIO INC · Health Care
ACT Capital Partners, L.P. reported holding 579,500 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$3.2M, representing 2.20% of its reported portfolio and ranking #13 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How ACT Capital Partners, L.P.'s NUVB position evolved
ACT Capital Partners, L.P. first disclosed a stake in NUVB in Q3 2026 at 579,500 shares (US$3.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 579.50K | $3.25M | New |
About NUVB and 13F data
NUVB (NUVATION BIO INC) is a Health Care company. 54 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$147.4M), Omega Fund Management, LLC (US$45.9M), Laurion Capital Management LP (US$44.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NUVB
- Decheng Capital LLC 25.95M sh · $147.42M · Q2 2026
- Omega Fund Management, LLC 8.08M sh · $45.90M · Q2 2026
- Laurion Capital Management LP 7.82M sh · $44.42M · Q2 2026
- Context Capital Management, LLC 30.00M sh · $31.29M · Q2 2026
- Polar Asset Management Partners Inc. 25.00M sh · $26.10M · Q2 2026
- Duquesne Family Office LLC 4.54M sh · $25.79M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M sh · $18.74M · Q2 2026
- Redmile Group, LLC 3.03M sh · $17.22M · Q2 2026
- Knoll Capital Management, LLC 1.60M sh · $9.08M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 1.34M sh · $7.53M · Q3 2026
- ABRAMS CAPITAL MANAGEMENT, L.P. 1.27M sh · $7.22M · Q2 2026
- TANAKA CAPITAL MANAGEMENT INC 901.83K sh · $3.87M · Q1 2026
More on ACT Capital Partners, L.P.
FAQ
How long has ACT Capital Partners, L.P. held NUVB?
ACT Capital Partners, L.P. has disclosed NUVB holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACT Capital Partners, L.P.'s current position in NUVB?
As of Q3 2026, ACT Capital Partners, L.P. holds 579.50K shares of NUVB (NUVATION BIO INC), valued at $3.25M, representing 2.20% of its reported portfolio and ranking #13.
Has ACT Capital Partners, L.P. been buying or selling NUVB?
In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in NUVB.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Omega Fund Management, LLC, Laurion Capital Management LP, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.